The CDC antimicrobial use measure is not ready for public reporting or value-based programs.
| Autor: | Shively NR; Division of Infectious Diseases, Allegheny Health Network, Pittsburgh, Pennsylvania., Morgan DJ; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland.; Veterans' Affairs (VA) Maryland Healthcare System, Baltimore, Maryland. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Antimicrobial stewardship & healthcare epidemiology : ASHE [Antimicrob Steward Healthc Epidemiol] 2023 Apr 19; Vol. 3 (1), pp. e77. Date of Electronic Publication: 2023 Apr 19 (Print Publication: 2023). |
| DOI: | 10.1017/ash.2023.143 |
| Abstrakt: | The standardized antimicrobial administration ratio (SAAR) is the metric for reporting antimicrobial use that hospitals will be mandated to use in 2024. We highlight limitations of the SAAR and caution against efforts to use it for public reporting and financial reimbursement. Before the SAAR is ready for public reporting, it needs to include patient-level risk adjustment and antimicrobial resistance data as well as improved hospital location options and revised antimicrobial agent groupings to appropriately reflect and incentivize important stewardship work. Competing Interests: All authors report no conflicts of interest relevant to this article. (© The Author(s) 2023.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|